查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2001149

急性期侧脑室引流市场：依产品类型、技术、引流方法、病患年龄层、应用、最终用户和通路划分－2026-2032年全球市场预测

Acute External Ventricular Drain Market by Product Type, Technology, Drainage Type, Patient Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，急性体外脑室引流市场价值将达到 2.9393 亿美元，到 2026 年将成长至 3.3064 亿美元，到 2032 年将达到 5.9444 亿美元，年复合成长率为 10.58%。

主要市场统计数据
基准年 2025 2.9393亿美元
预计年份：2026年 3.3064亿美元
预测年份 2032 5.9444亿美元
复合年增长率 (%) 10.58%

简要概述了影响现代神经重症监护环境中急性侧脑室引流使用的不断变化的临床、监管和运营环境。

急性侧脑室引流（EVD）系统仍然是神经重症监护的基石，在脑脊髓液排放、颅内压监测和急诊神经外科手术中发挥着至关重要的作用。近期的临床实践强调对水脑症、蜘蛛网膜下腔出血、创伤性脑损伤和复杂性颅内高压患者进行基于通讯协定的快速介入。因此，临床医生和医疗系统需要在临床疗效、感染预防、易用性和工作流程效率之间取得平衡。这些优先事项影响急症护理机构的采购考量和采购流程。

感染控制重点、分散式照护路径和采购政策如何以总体拥有成本 (TCO) 为中心，从而改变医疗设备的设计和商业化策略？

近年来，医院和专科医疗中心用于急性期的体外脑室引流管的设计、供应和使用发生了变革性变化。临床上，最大限度地减少感染和提高监测精度变得日益重要，这推动了封闭式系统技术和整合压力感测功能的应用。同时，在医疗服务模式中，某些神经外科手术向门诊手术中心和专科诊所的分散化，正在改变需求模式并影响库存策略。

本报告预测了美国关税结构调整对商业性和供应链的影响，以及製造商和医疗保健系统在 2025 年应考虑的策略选择。

美国计划于2025年调整关税政策，将对医疗设备（包括组件和组装急性护理用外脑室引流管）的采购和整个供应链产生重大影响。关税调整将影响进口原材料和成品的到货成本，进而可能影响筹资策略、与供应商的谈判以及国内外工厂之间的产能分配。因此，采购团队和製造商必须评估供应商合约、避险策略以及最终用户可能面临的价格上涨风险，同时也要考虑到医院的预算限制。

一项基于细分市场的综合评估，揭示了临床适应症、医疗保健环境、产品架构和分销管道如何全面影响医疗器材的设计和商业性部署路径。

細項分析揭示了每种临床应用、最终用户、产品类型、技术、引流方法、患者群体和分销管道的不同驱动因素和采用路径。依应用领域划分，医疗设备设计和临床工作流程直接满足诸如水脑症管理、颅内压监测、蜘蛛网膜下腔出血治疗和创伤性脑损伤管理等需求，每种适应症对监测精度、导管耐用性和感染控制都有独特的要求。就最终用户而言，门诊手术中心、医院和专科诊所在手术量、消毒能力和采购权限方面的差异，影响预组装一次性套件与基于集中式再处理系统的吸引力比较。

全球神经重症监护市场趋势、监管义务、区域趋势和医疗保健系统特征决定了商业策略。

区域趋势影响着美洲、欧洲、中东和非洲以及亚太地区的部署模式、监管预期和竞争程度，每个地区都面临独特的机会和挑战。在美洲，先进的神经重症监护能力、集中的三级神经病学中心以及整合的医院采购框架正在推动功能丰富的封闭式系统和先进的一次性耗材包的普及，而私人和公共保险公司的发展趋势则影响着部署时间和合约结构。对过渡期照护模式和打包支付的重视，促使医疗系统优先选择那些能够降低感染率和缩短住院时间的医疗设备。

竞争格局凸显了规模、临床证据和服务整合如何决定供应商差异化和市场定位。

急性侧脑室引流领域的竞争动态由成熟的医疗技术公司、专业的神经外科医疗设备製造商和灵活的利基创新者组成。大型製造商利用其规模、全球分销网络和广泛的临床产品组合来获得医院合同，并提供包括培训、上市后监测和服务协议在内的复杂价值提案。同时，小规模的专业公司正在推动导管设计、封闭式系统技术和整合监测功能的创新，他们通常与临床中心合作，以检验产品性能并加速临床医生采用这些技术。

製造商和医疗保健系统在神经重症监护领域提高临床疗效、供应链韧性和差异化商业性可行性的具体策略重点。

产业领导者应优先考虑在保障临床疗效的同时，简化供应链和商业性执行流程。首先，应投资于临床研究和真实世界数据（REW）项目，量化感染率、ICU住院时间和器械相关併发症的降低情况，从而为采购谈判和报销方案的调整提供支持。其次，应优化产品系列，涵盖一次性高级套装和可重复使用系统，使医疗机构能够选择符合自身消毒能力和成本控制目标的解决方案。在优化产品的同时，也应透过双重采购、关键零件的近岸外包以及针对关税导致的成本变化製定明确的紧急时应对计画，来增强供应链的韧性。

采用严谨的混合方法，结合医疗保健专业人员的见解、监管审查和情境建模，确保对医疗设备、临床实务和供应链的趋势进行全面、检验的分析。

本执行摘要的调查方法融合了定性和定量方法，以确保证据基础的稳健性和解读的平衡性。主要资料来源包括对临床负责人、采购负责人和工程团队的结构化访谈，并辅以典型临床实务流程的观察分析。次要资料来源则利用同侪审查的临床文献、监管文件、医疗设备标籤和製造商产品规格，以支持技术能力和安全性方面的论点。

整合临床、营运和商业性需求，以确定哪种策略方法能够带来可持续的实施和患者照护。

总之，体外脑室引流系统在急性护理中占据着至关重要的地位，它融合了临床需求、操作要求和商业性复杂性。儘管临床上日益重视感染控制和监测准确性，导致许多医疗机构倾向于使用密封系统和精心配置的一次性耗材包，但在无菌基础设施能够实现经济高效重复使用的环境中，可重复使用系统仍然具有重要的战略意义。为了适应不断变化的收费系统和区域采购趋势，需要製定前瞻性的供应链和商业计划，以维持供应的稳定性和获利能力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：急性期侧脑室引流市场：依产品类型划分

  • 免洗工具包
    • 高级套件
    • 标准套件
  • 可重复使用系统
    • 多配置系统
    • 单配置系统

第九章：急性期侧脑室引流市场：依技术划分

  • 封闭式系统
  • 开放系统

第十章：急性期侧脑室引流市场－依引流类型划分

  • 连续排水
  • 间歇性排水

第十一章：依病患年龄组别分類的急性期侧脑室引流市场

  • 成人版
  • 儿童

第十二章：急性护理侧脑室引流市场：依应用领域划分

  • 水脑症的治疗
  • 颅内压监测
  • 蜘蛛网膜下腔出血的治疗
  • 创伤性脑损伤的治疗

第十三章：急性护理侧脑室引流市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十四章：急性期侧脑室引流市场：依通路划分

  • 销售代理
    • 医疗设备批发商
    • 药品批发商
  • 电子商务
    • 製造商网站
    • 第三方网站
  • 医院供应商
    • 与医院直接签订合约
    • 集团采购组织

第十五章：急性期侧脑室引流市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章：急性期侧脑室引流市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章：急性护理侧脑室引流市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国急性护理侧脑室引流市场

第十九章：中国急性照护侧脑室引流市场。

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Argi Group GmbH
  • B. Braun Melsungen AG
  • Christoph Miethke GmbH & Co. KG
  • DePuy Synthes
  • Elektron Instruments LLP
  • Hanni Medizintechnik GmbH
  • Head Sense Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Medtronic plc
  • Moller Medical GmbH
  • Natus Medical Incorporated
  • Neurologic Ltd.
  • Raumedic AG
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
  • Stryker Corporation
Product Code: MRR-957C47F8FEC9

The Acute External Ventricular Drain Market was valued at USD 293.93 million in 2025 and is projected to grow to USD 330.64 million in 2026, with a CAGR of 10.58%, reaching USD 594.44 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 293.93 million
Estimated Year [2026] USD 330.64 million
Forecast Year [2032] USD 594.44 million
CAGR (%) 10.58%

A concise orientation to the evolving clinical, regulatory, and operational context shaping acute external ventricular drain use across modern neurocritical care settings

Acute external ventricular drain (EVD) systems remain a cornerstone of neurocritical care, playing a critical role in cerebrospinal fluid diversion, intracranial pressure monitoring, and emergency neurosurgery. Recent clinical practice has emphasized rapid, protocol-driven interventions for patients with hydrocephalus, subarachnoid hemorrhage, traumatic brain injury, and complex intracranial hypertension. Consequently, clinicians and healthcare systems are balancing the need for clinical efficacy with infection prevention, ease of use, and workflow efficiency. These priorities have shaped purchasing considerations and procurement pathways across acute care settings.

Technology developments and changing care pathways have begun to alter expectations of EVD devices, from single-use, prepackaged kits to more modular reusable systems designed for sustainable operational models. At the same time, regulatory scrutiny around device sterility, post-market surveillance, and clinical outcomes has intensified, prompting manufacturers to strengthen evidence packages. Taken together, these dynamics create a landscape in which clinical demand, hospital operational constraints, and regulatory imperatives converge to influence device design, distribution, and adoption.

How infection-control priorities, decentralized care pathways, and procurement focus on total cost of ownership are reshaping device design and commercialization strategies

The last several years have witnessed transformative shifts in how acute external ventricular drains are designed, supplied, and used within hospitals and specialty centers. Clinically, there is growing emphasis on minimizing infection and improving monitoring precision, which has driven adoption of closed-system technologies and integrated pressure-sensing capabilities. At the same time, healthcare delivery models are decentralizing certain neurosurgical procedures to ambulatory surgical centers and specialty clinics, altering demand patterns and influencing stocking strategies.

Moreover, procurement teams are increasingly focused on total cost of ownership, favoring disposable kits that reduce reprocessing burdens while also exploring reusable systems that can be optimized through robust sterilization protocols. Digital health integration and remote monitoring are beginning to appear in adjacent device ecosystems, and regulatory frameworks have tightened around traceability and adverse event reporting, prompting manufacturers to prioritize post-market data collection. These converging shifts are prompting incumbent suppliers and new entrants to reassess product roadmaps and commercial strategies to align with clinician preferences and institutional imperatives.

Anticipating the commercial and supply chain consequences of United States tariff realignment and the strategic choices manufacturers and health systems must weigh in 2025

United States tariff policy changes projected for 2025 introduce material considerations across the procurement and supply chain landscape for medical devices, including components and assembled acute external ventricular drains. Tariff adjustments affect the landed cost of imported materials and finished devices, which in turn can influence sourcing strategies, supplier negotiations, and the allocation of manufacturing capacity between domestic and offshore facilities. Procurement teams and manufacturers must therefore evaluate supplier contracts, hedging strategies, and potential price pass-through to end users while remaining mindful of hospital budget constraints.

In response, manufacturers may intensify efforts to localize production, qualify alternative suppliers, or redesign product kits to reduce reliance on tariff-impacted components. Hospitals and group purchasing organizations will likely increase scrutiny of contract terms and inventory practices, seeking greater transparency on cost drivers. Importantly, tariff-related cost pressures can also accelerate interest in disposable kits that simplify logistics, or conversely, renew focus on reusable systems where capital investment and local sterilization can mitigate import exposure. Navigating this environment requires coordinated scenario planning between commercial, regulatory, and supply chain teams to preserve margins while sustaining clinical availability.

A comprehensive segmentation-driven assessment revealing how clinical indications, care settings, product architectures, and distribution channels collectively influence device design and commercial pathways

Segmentation analysis reveals differentiated drivers and adoption pathways across clinical applications, end users, product typologies, technologies, drainage approaches, patient demographics, and distribution modalities. By application, device design and clinical workflows respond directly to needs in hydrocephalus management, intracranial pressure monitoring, subarachnoid hemorrhage treatment, and traumatic brain injury management, with each indication imposing unique requirements for monitoring fidelity, catheter durability, and infection control measures. Regarding end users, ambulatory surgical centers, hospitals, and specialty clinics vary in procedural volume, sterile processing capabilities, and purchasing authority, shaping the appeal of preassembled disposable kits versus systems intended for centralized reprocessing.

Product type segmentation highlights a tension between disposable kits and reusable systems. Disposable kits, which include advanced and standard configurations, appeal where single-use sterility and simplified procedural setup reduce infection risk and staff time, whereas reusable systems, available as multi-component and single-component formats, can be preferable where sterilization infrastructure and throughput support cost amortization. Technology segmentation separates closed systems from open systems; closed systems typically reduce contamination risk and support clinician preference in intensive care environments, while open systems retain relevance where simplicity and cost are paramount. Drainage type stratification into continuous versus intermittent approaches affects drainage hardware and monitoring cadence, and patient age segmentation into adult and pediatric populations drives design differences in catheter size, monitoring thresholds, and caregiver training. Finally, distribution channels encompass distributors, ecommerce, and hospital vendors; distributor categories include medical device and pharmaceutical distributors, ecommerce pathways traverse manufacturer websites and third-party platforms, and hospital vendors operate through direct hospital contracts and group purchasing organizations. Each distribution pathway requires tailored commercial engagement strategies, contractual constructs, and logistics planning to align product availability with clinical demand.

Regional dynamics and healthcare system nuances that determine adoption trajectories, regulatory obligations, and commercial strategies across global neurocritical care markets

Regional dynamics shape adoption patterns, regulatory expectations, and competitive intensity across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct opportunities and constraints. In the Americas, advanced neurocritical care capacity, concentration of tertiary neurological centers, and integrated hospital procurement frameworks favor adoption of feature-rich closed systems and advanced disposable kits, while private and public payor dynamics influence acquisition timing and contract structures. Transitional care models and emphasis on bundled payments prompt health systems to prioritize devices that demonstrate reductions in infection rates and length of stay.

Across Europe, Middle East & Africa, regulatory harmonization efforts and national reimbursement policies influence market entry and adoption. In Western Europe, stringent device regulations and high standards for clinical evidence drive manufacturers to invest in post-market studies and value demonstrations, whereas in parts of the Middle East and Africa, infrastructure variability creates pockets of demand for both cost-effective reusable systems and readily available disposable kits. In the Asia-Pacific region, rapidly expanding neurosurgical capacity, strong local manufacturing ecosystems, and evolving regulatory pathways create opportunities for both global suppliers and regional manufacturers. Price sensitivity in some markets coexists with rising demand for advanced solutions in urban tertiary centers, prompting manufacturers to offer differentiated product tiers and flexible commercial models tailored to regional needs.

Competitive landscape characterization highlighting how scale, clinical evidence, and service integration determine supplier differentiation and market positioning

Competitive dynamics in the acute external ventricular drain space are shaped by a mix of established medtech firms, specialized neurosurgical device companies, and agile niche innovators. Larger manufacturers leverage scale, global distribution networks, and broad clinical portfolios to secure hospital contracts and support complex value propositions that include training, post-market surveillance, and service agreements. Conversely, smaller specialized firms drive innovation around catheter design, closed-system technology, and integrated monitoring features, often partnering with clinical centers to validate performance and accelerate clinician acceptance.

Collaboration between original equipment manufacturers and contract manufacturers has deepened, enabling faster product iterations and cost optimization while also dispersing supply chain risk. Strategic differentiation increasingly relies on clinical evidence generation, infection mitigation features, and lifecycle service offerings rather than on price alone. In addition, channel strategies vary: some suppliers emphasize direct hospital contracts and group purchasing organization participation, while others exploit distributor networks and digital channels to expand reach. Ultimately, competitive positioning depends on the ability to align clinical claims with operational value and to demonstrate measurable improvements in patient outcomes and workflow efficiencies.

Actionable strategic priorities for manufacturers and health systems to fortify clinical outcomes, supply resilience, and differentiated commercial execution in neurocritical care

Industry leaders should prioritize actions that safeguard clinical performance while streamlining supply and commercial execution. First, invest in clinical studies and real-world evidence programs that quantify reductions in infection rates, ICU duration, and device-related complications to support procurement discussions and reimbursement alignment. Second, optimize product portfolios to cover both disposable advanced kits and reusable system options, allowing institutions to select solutions that align with their sterilization capabilities and cost-management objectives. Parallel to product optimization, strengthen supply chain resilience through dual sourcing, nearshoring critical components, and clear contingency planning for tariff-driven cost shifts.

Commercially, tailor engagement models by end user and region, offering flexible contract terms, training packages, and evidence-backed value propositions for ambulatory surgical centers, hospitals, and specialty clinics. Embrace digital channels and manufacturer-owned ecommerce to support rapid replenishment and to capture demand from decentralized care sites. Finally, collaborate with clinical leaders to co-develop protocols that simplify device setup and maintenance, thereby reducing variability in outcomes and enhancing the perceived value of premium device attributes.

A rigorous mixed-methods approach combining clinician insight, regulatory review, and scenario modeling to ensure comprehensive and validated analysis of device, clinical, and supply chain dynamics

The research methodology for this executive summary integrates qualitative and quantitative approaches to ensure a robust evidence base and balanced interpretation. Primary inputs include structured interviews with clinical leaders, procurement professionals, and engineering teams, complemented by observational analysis of procedural workflows in representative care settings. Secondary inputs draw on peer-reviewed clinical literature, regulatory documentation, device labeling, and manufacturer product specifications to substantiate technology capabilities and safety profiles.

Analytical techniques employed include comparative feature mapping across product typologies, scenario-based supply chain modeling to assess tariff impacts, and segmentation analysis to identify distinct demand clusters by application, end user, and distribution channel. Wherever possible, findings were cross-validated through clinician expert panels and technical reviews to ensure practical relevance. Limitations and data gaps were explicitly identified, with recommended follow-up research areas to deepen insight into long-term clinical outcomes and device lifecycle economics.

Synthesis of clinical, operational, and commercial imperatives that determines which strategic approaches will deliver sustained adoption and measurable patient-care improvements

In conclusion, acute external ventricular drain systems occupy a critical intersection of clinical necessity, operational imperatives, and commercial complexity. Clinical emphasis on infection control and monitoring precision is tilting preference toward closed systems and carefully configured disposable kits in many care settings, even as reusable systems retain strategic importance where sterilization infrastructure supports cost-effective reuse. Tariff changes and regional purchasing dynamics require proactive supply chain and commercial planning to sustain availability and preserve margin structures.

Manufacturers that pair strong clinical evidence with flexible product portfolios, resilient sourcing strategies, and targeted regional commercial approaches will be best positioned to meet evolving clinician and purchaser expectations. Health systems and procurement teams, by contrast, will benefit from clearer total cost of ownership analyses, tighter protocol alignment, and selective adoption of devices that demonstrably reduce complications and workflow burden. Continued collaboration between clinical stakeholders, manufacturers, and supply chain partners will be essential to translate innovation into measurable improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acute External Ventricular Drain Market, by Product Type

  • 8.1. Disposable Kits
    • 8.1.1. Advanced Kits
    • 8.1.2. Standard Kits
  • 8.2. Reusable Systems
    • 8.2.1. Multi Component Systems
    • 8.2.2. Single Component Systems

9. Acute External Ventricular Drain Market, by Technology

  • 9.1. Closed Systems
  • 9.2. Open Systems

10. Acute External Ventricular Drain Market, by Drainage Type

  • 10.1. Continuous Drainage
  • 10.2. Intermittent Drainage

11. Acute External Ventricular Drain Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Pediatric

12. Acute External Ventricular Drain Market, by Application

  • 12.1. Hydrocephalus Management
  • 12.2. Intracranial Pressure Monitoring
  • 12.3. Subarachnoid Hemorrhage Treatment
  • 12.4. Traumatic Brain Injury Management

13. Acute External Ventricular Drain Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. Acute External Ventricular Drain Market, by Distribution Channel

  • 14.1. Distributors
    • 14.1.1. Medical Device Distributors
    • 14.1.2. Pharmaceutical Distributors
  • 14.2. Ecommerce
    • 14.2.1. Manufacturer Websites
    • 14.2.2. Third Party Websites
  • 14.3. Hospital Vendors
    • 14.3.1. Direct Hospital Contracts
    • 14.3.2. Group Purchasing Organizations

15. Acute External Ventricular Drain Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Acute External Ventricular Drain Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Acute External Ventricular Drain Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Acute External Ventricular Drain Market

19. China Acute External Ventricular Drain Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Argi Group GmbH
  • 20.6. B. Braun Melsungen AG
  • 20.7. Christoph Miethke GmbH & Co. KG
  • 20.8. DePuy Synthes
  • 20.9. Elektron Instruments LLP
  • 20.10. Hanni Medizintechnik GmbH
  • 20.11. Head Sense Medical, Inc.
  • 20.12. Integra LifeSciences Holdings Corporation
  • 20.13. LivaNova PLC
  • 20.14. Medtronic plc
  • 20.15. Moller Medical GmbH
  • 20.16. Natus Medical Incorporated
  • 20.17. Neurologic Ltd.
  • 20.18. Raumedic AG
  • 20.19. Sophysa SA
  • 20.20. Spiegelberg GmbH & Co. KG
  • 20.21. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 260. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 263. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 268. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 273. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 280. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 281. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD